Development asset linked to Beijing Tiantan Hospital in public FDA and regional records. Molecular target: Tissue-type plasminogen activator.
- Target
- Tissue-type plasminogen activator
- Mechanism
- Tissue-type plasminogen activator exogenous protein
pharma · Acute Ischemic Stroke
Beijing Tiantan Hospital
Beijing Tiantan Hospital drug portfolio — 2 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Beijing, CN HQ
124 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- Beijing, CN
- Employees
- 124
- Programs
- 1
- Drugs
- 2
- Patents
- 0
Beijing Tiantan Hospital pipeline
Portfolio lens on 2 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Beijing Tiantan Hospital drug portfolio — 2 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
Development asset linked to Beijing Tiantan Hospital in public FDA and regional records.